Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

The nonpartisan advert encourages the public to get involved in local town halls and to be civil with peers. Images of the ...

The General Overseer of the Redeemed Christian Church of God, RCCG, Pastor E. A. Adeboye, has distanced himself from a viral ...

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

就在最近，一个名为 OpenBioMed 的智能体平台低调亮相，率先对外开源开放。作为全球首个AI制药领域的智能体开源平台，生命科学领域、制药领域的研发人员人人可用。 以及虽然是新团队，但核心人物却是AI老面孔—— 大牛聂再清 ，他是水木分子的首席科学家，也是前天猫精灵背后的首席AI科学家，一个因为AI骚扰电话不堪其扰而打造“二哈”反骚扰AI的硬核程序员。

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...